Pharmaceutical Preparations · DE · CIK 1422142
Clinical-stage oncology company developing antibody drug conjugates for cancer treatments
Comparable business profile · signals at a glance
In the 90 days to Mar 2, 2026: 3 sold $32K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Lennon David JamesCHIEF EXECUTIVE OFFICER | Sell | 5,100 | $3.31 | $17K |
| Mar 2, 2026 | Giacobello Scott M.CHIEF FINANCIAL OFFICER | Sell | 2,594 | $3.31 | $9K |
| Mar 2, 2026 | Ball BryanSee remarks | Sell | 1,834 | $3.31 | $6K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.